Analyst Research

Report Title Price
Provider: Thomson Reuters Stock Report
$25.00
Provider: New Constructs, LLC
$25.00
Provider: Wright Reports
$75.00
Provider: ValuEngine, Inc.
$25.00

NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.

Solazyme Inc Revises FY 2013 Revenue Guidance To A Range Below Analysts' Estimates-Conference Call


Tuesday, 5 Nov 2013 09:30pm EST 

Solazyme Inc announced that it has revised fiscal 2013 revenue guidance to between $40 million and $42 million. According to I/B/E/S Estimates, analysts on an average are expecting the Company to report revenue of $47 million for fiscal 2013. 

Company Quote

9.68
-0.68 -6.56%
4:00pm EDT